Table 2.
Treatment algorithm for nail psoriasis
Hitherto untreated mild NP (three nails, NAPSI <16) | Topical steroid class III–IV Steroid plus calcipotriol | ||
| |||
No improvement | Injections (steroids, methotrexate) | ||
| |||
No improvement | Systemic antipsoriatics (MTX, CyA [FAE]) | More than three nails, NAPSI >16. Unsuccessfully pretreated | Systemic antipsoriatics (MTX, CyA [FAE]) |
| |||
No improvement | Biologicals: TNF-α inhibitor | No improvement | Biologicals: TNF-α inhibitor |
| |||
If TNF-α inhibitors no longer active or show a paradox worsening | IL-12/23 or IL-17 inhibitor | ||
| |||
If IL-12/23 or IL-17 inhibitors no longer active | Selective p19 inhibitor (IL-23) |
Abbreviations: CyA, cyclosporin A; FAE, fumaric acid ester; MTX, methotrexate; NP, nail psoriasis; NAPSI, nail psoriasis severity index.